AnaptysBio, Inc.ANABNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+71.3%
5Y CAGR+57.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+71.3%/yr
vs +23.9%/yr prior
5Y CAGR
+57.8%/yr
Recent acceleration
Acceleration
+47.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
9.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $184.28M | +334.7% |
| 2024 | $42.39M | -14.0% |
| 2023 | $49.28M | +34.5% |
| 2022 | $36.64M | +70.5% |
| 2021 | $21.49M | +14.0% |
| 2020 | $18.85M | +17.1% |
| 2019 | $16.09M | +3.7% |
| 2018 | $15.53M | +66.3% |
| 2017 | $9.34M | +117.7% |
| 2016 | $4.29M | - |